États-Unis · Plateformes & données · MarketBeat

Retension Pharmaceuticals, Inc.'s (NASDAQ:RTSN) Quiet Period To End on November 18th

Publié par MarketBeat · États-Unis il y a 25 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Retension Pharmaceuticals' (NASDAQ:RTSN - Get Free Report) quiet period is set to end on Wednesday, November 18th. Retension Pharmaceuticals had issued 3,750,000 shares in its public offering on October 9th. The total size of the offering was $45,000,000 based on an initial share price of $12.00.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Retension Pharmaceuticals, Inc.'s (NASDAQ:RTSN) Quiet Period To End on November 18th

Résumé détaillé

À lire aussi

Ares Dynamic Credit Allocation Fund declares $0.1125 dividend

Swarmer (SWMR) Q3 2026 Earnings Call Transcript

Kirin Holdings 9-mth profit rises 18% on strong alcohol sales

Alibaba announces plans to list T-Head, its Nvidia chip rival

‘The thought of living to 100 terrifies me’: Is Social Security a giant Ponzi scheme?

SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%

Retension Pharmaceuticals, Inc.'s (NASDAQ:RTSN) Quiet Period To End on November 18th

Résumé détaillé

Partager

À lire aussi

Ares Dynamic Credit Allocation Fund declares $0.1125 dividend

Swarmer (SWMR) Q3 2026 Earnings Call Transcript

Kirin Holdings 9-mth profit rises 18% on strong alcohol sales

Alibaba announces plans to list T-Head, its Nvidia chip rival

‘The thought of living to 100 terrifies me’: Is Social Security a giant Ponzi scheme?

SLS Stock Rises After-Hours: State Street Reveals Over 5% Stake — And One Fund Manager Boosted Holdings By Nearly 1,000%